Company intelligence / Profile preview
Cryopraxis
- Ownership
- Private
- Development stage
- Phase 2
Overview
Cryopraxis operates the largest cryogenic storage facility and umbilical cord blood bank in Brazil. It has processed over 25,000 cord blood units and sponsors multiple R&D projects domestically and internationally. The company runs clinical trials involving autologous/adipose/menstrual/cord-blood derived stem cells for various indications including COVID-related syndromes, angina pectoris, endometriosis diagnosis, stress urinary incontinence treatment.
- Therapeutic areas
- OtherWomen's HealthCardiovascularInfectious Diseases
- Modalities
- Stem cells (umbilical cord blood, bone marrow, adipose tissue, menstrual blood)Plasma-derived therapiesMesenchymal stem cells
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Cryopraxis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cryopraxis.